NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
721.00
-77.00 (-9.65%)
Dec 10, 2025, 3:30 PM KST
-28.97%
Market Cap78.90B
Revenue (ttm)94.29M
Net Income (ttm)-29.66B
Shares Out98.87M
EPS (ttm)-92.75
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,280,011
Average Volume4,661,146
Open798.00
Previous Close798.00
Day's Range705.00 - 814.00
52-Week Range540.00 - 1,881.00
Beta0.51
RSI60.96
Earnings DateNov 14, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 52
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.